Muse company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

choosemuse.com

Founded Year

2009

Stage

Series C | Alive

Total Raised

$41.26M

Last Raised

$9.5M | 10 days ago

Mosaic Score

+220 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Muse

InteraXon, the creator of Muse, creates and implements brainwave-controlled computing technology and applications, as well as an ongoing awareness of advances in the field. The InteraXon technology is a software and hardware infrastructure that lets users control almost anything using only the mind. It works by converting brainwaves into digital signals that are fed into a computer. Furniture, audio & visual devices, and toy cars are all controllable without the touch of a button. Muse was founded in 2009 and is based in Toronto, Ontario.

Muse Headquarters Location

555 Richmond Street West Suite 900

Toronto, Ontario, M5V 3B1,

Canada

(888) 508-6873

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Muse

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Muse in 3 CB Insights research briefs, most recently on May 24, 2021.

Expert Collections containing Muse

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Muse is included in 8 Expert Collections, including Mental Health Tech.

M

Mental Health Tech

1,228 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.

W

Wearable Computing

408 items

Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.

C

Conference Exhibitors

6,062 items

Companies that will be exhibiting at CES 2018

W

Wellness Tech

1,313 items

We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.

S

Sleep Health & Wellness

801 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.

S

Smart Home & Consumer Electronics

1,165 items

This Collection includes companies developing smart home devices, wearables, home electronics, and other consumer electronics.

Muse Patents

Muse has filed 17 patents.

The 3 most popular patent topics include:

  • Electronic test equipment
  • Sensors
  • Asus products
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/4/2018

9/8/2020

IPad, Asus products, LG computers, Personal computing, Personal digital assistants

Grant

Application Date

10/4/2018

Grant Date

9/8/2020

Title

Related Topics

IPad, Asus products, LG computers, Personal computing, Personal digital assistants

Status

Grant

Latest Muse News

Interaxon Inc. (Muse®) Announces $9.5M Series C Funding Round To Expand Brain Health and Wellness Offerings

Aug 11, 2022

The Funding Will Support New Research Initiatives Around Brain Health and Increasing Accessibility to The Company’s EEG Technology Platform August 11, 2022 10:01 AM Eastern Daylight Time TORONTO--( BUSINESS WIRE )--Interaxon Inc. ( Muse® ), the leading consumer neurotechnology company, announced that it has closed an oversubscribed $9.5M USD Series C funding round through a non-brokered private placement. The round was led by BDC Capital, Alabaster (family office of Sunny Vu, founder of Misfit), and Export Development Canada, along with new institutional investors including Phyto Partners, Iter Investments, Intretech(HK) Co, and The Clavis Foundation. Co-founder Ariel Garten also participated in the round. As a result of the strong market interest, the Company has opened an allotment for additional oversubscription, with a second (final) close planned by the end of Q3 for strategic investment. With this funding, Interaxon aims to enrich its leading brain health platform through launching an integrated wellness membership model and further research and validation of an industry-first feature tracking longitudinal changes in the brain. Interaxon will also support expanding offerings for third-party developers, researchers, clinicians and other strategic partnerships. “At Muse, we’re passionate about supporting the neuroscience research community,” said Ariel Garten, co-founder of Interaxon. “We are excited for the value this funding will unlock, including the development and validation of an industry first, user-friendly EEG measurement showing changes in brain age that can provide value in a variety of research and clinical settings.” The Membership Shift: Increasing Accessibility to Brain Health Tools Expanding their brain health platform offerings, Muse’s first-ever brain performance measurement will allow users to compare themselves to various groups across the broader population, and against their own historical values over time. A recent discovery from Muse’s R&D team has showcased exciting new patterns in their extensive EEG database with strong indications of brain health. The Company aims to leverage these patterns through the development of groundbreaking metrics that will provide users meaningful insights into brain health and lifestyle factors (i.e. meditation, sleep, alcohol, stress, exercise, diet, etc.) that affect it. These personalized insights along with other new biosensor trend reports will roll out later this year, and will be included in the new membership program. The new membership model, launching in Q1 2023, provides a lower-cost entry for customers to try advanced wearable EEG technology without the high upfront cost. Members will have access to participate in community research initiatives, continuous expert support, ongoing content updates, headband replacements and new device models, when available. This offering is strategic to Muse’s ongoing commitment to be a long-term wellness partner, providing new and innovative ways for users to gain deeper insight into their brain health and overall well-being. Investor Quote: Lally Rementilla, Managing Partner of BDC Capital said, “We’re proud to support Muse in their pursuit of continually providing users with not only a deeper understanding of their brain health and overall wellbeing, but interventions that support them when they need it. It’s a privilege to partner with Muse as they continue to expand their product offerings and extensive IP portfolio.” Investor Quote: Larry Schnurmacher, Managing Partner at Phyto Partners, said, “The innovation happening in and around neuro-wellness and brain health space is accelerating and we are privileged to support Muse in their mission to not only provide a wider audience offering, but also in providing the research community and SDK partners with tools to further the transformation of this space.” The Company will also invest in key strategic partnerships including SDK and research partnerships opportunities that leverage their world leading EEG technology platform in the development of data-driven studies and systems that will support the advancement of neuroscience, neurotechnology and brain health at large. To learn more about Interaxon’s investment opportunities contact Derek Luke, CEO of Interaxon, at derek@interaxon.ca . About Interaxon Inc.: Interaxon is a late-stage venture company in the neurotechnology space, with a brain and biosensor platform of hardware and software products, a sophisticated data-cloud infrastructure, popular consumer and licensable B2B products, the largest database of brain data in the world, and an IP fortress with several fundamental granted brain, biosignal, VR and AR patents with early priority dates. Interaxon is currently completing a second investment round to support converting the company's current up-front cost model to an integrated subscription model. Interaxon is headquartered in Toronto, Canada, and has subsidiaries in the U.S. and Ireland. Milestones we’re excited about: Community: More than 500,000 Musers globally Sessions of meditation with Muse®: Over 100 million minutes to date and currently one of the largest brain data (EEG) collections in the world. Research institutions using Muse®: The Mayo Clinic, NASA, Harvard, MIT, U of T, UCL, UCSD, Inria, UVic, UBC, and many more. Meditating with Muse® works: Muse has been used in over 200 published studies, including Mayo Clinic who demonstrated meditating with Muse increases quality of life, and decreases stress and fatigue in cancer patients. Better Sleep with Muse® : A recent 2021 study with ~200 participants led by Western University, Cambridge Brain Science, Hatch, and Interaxon that used Muse S EEG-sleep support technology showed a 20% improvement in the Pittsburgh Sleep Quality Index (PSQI) after 6 weeks of following Muse protocols. Untangle Podcast : With more than 11 million listens, and growing daily, Untangle® hosts Patricia Karpas and Ariel Garten interview thought-provoking authors, experts and leaders in areas related to neuroscience, mindfulness, sleep, brain health practices, and more.

Muse Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Muse Rank

  • When was Muse founded?

    Muse was founded in 2009.

  • Where is Muse's headquarters?

    Muse's headquarters is located at 555 Richmond Street West, Toronto.

  • What is Muse's latest funding round?

    Muse's latest funding round is Series C.

  • How much did Muse raise?

    Muse raised a total of $41.26M.

  • Who are the investors of Muse?

    Investors of Muse include Export Development Canada, Iter Investments, Intertech, Alabaster, BDC Capital and 15 more.

  • Who are Muse's competitors?

    Competitors of Muse include Healium, NextMind, Neauphony, Reflect Innovation, Freer Logic and 7 more.

You May Also Like

NeuroSky Logo
NeuroSky

NeuroSky is at the forefront of body and mind monitoring and analysis. Its technologies are at the core of innovative, wearable health and wellness consumer products. NeuroSky makes it possible for millions of consumers to capture and quantify critical health and wellness data so that they can effectively manage their mind and body health. NeuroSky delivers uniquely adaptable chips and algorithms that offer ECG multi-function cardio monitoring, and quantitive and interpretive algorithms in a powerful integrated, adaptable and extensible solution.

EMOTIV Logo
EMOTIV

Emotiv Systems, dba EMOTIV, aims to create an interface for the next-generation of human-machine interaction, by evolving the interaction between humans and electronic devices beyond the limitations of conscious interface. EMOTIV has created technologies that allow machines to take both conscious and non-conscious inputs directly from the mind. Applications for EMOTIV technology span numerous industries, however, their immediate target market is entertainment, with a focus on the electronic games industry.

eSight Logo
eSight

eSight creates electronic glasses that restore or enhance sight for individuals living with vision loss. Worn comfortably like a normal pair of glasses or with prescription lenses built-in, they allow a person with low vision to see in virtually the same manner as someone who is fully-sighted can. The company's SPEX enhances vision for precision tasks, allowing users to pan and zoom the real world or streamed images, and brings critical information to the point of task without overwriting or obstructing natural vision for full situational awareness and mobility.

R
River Diagnostics

River Diagnostics is dedicated to the development of products for the healthcare and medical research marketplace based on the vast potential of non-invasive/non-destructive Raman spectroscopy. Today researchers in personal care, and dermatological research are using River Diagnostics' instruments to understand the metabolic processes in the skin, and other fundamental research questions.

Calm Logo
Calm

Calm provides a relaxation and self-improvement service accessible through its website and mobile application. Calm offers a free app but also has a paid subscription offering which provides customers with access to a full library of meditation, music and sleep content.

D
DERMING SRL

DermIng, an independent private research Institute, carries out a series of clinical trials to measure the activity and tolerance of skin care treatments and products, and also developers the very latest non-invasive diagnostic bio-engineering systems.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.